Priority Date: 21.12.06 (US 20060876145P)

4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour

  • Application ID: EP14153703
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna becker kurig straus
no operation time available
Headquarter in Munich and 2 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Becker Kurig Straus is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 21.12.2006 - Priority Date (US 20060876145P)
  • 30.07.2014 - Publication A2 (EP2759302)
  • 05.11.2014 - Publication A3 (EP2759302)

IPC Classification